University Health Network, Toronto: Hyperlipidemias trials

The registry lists 10 Hyperlipidemias studies with University Health Network, Toronto as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 2 6Phase 3 6No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in HumansCompletedNCT01600703Phase 2/3Results posted
• Effects of Oral Glucose and Teduglutide on Plasma LipoproteinsStatus unknownNCT03860688Phase 2/3
• L-NMMA on GLP-2 Mediated Intestinal Lipoprotein ReleaseCompletedNCT03534661Phase 2/3
• Glucose-stimulated Gut Lipid ReleaseCompletedNCT03464240Not applicable
• Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral LipidsCompletedNCT03442972Phase 2/3
• Plasma Lipid Response to Glucose DrinkCompletedNCT03435432Not applicable
• Plasma Lipoprotein Response to Glucagon-like Peptide-2CompletedNCT03422666Phase 2/3
• The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein ProductionCompletedNCT03141827Phase 2/3
• Regulation of Intestinal and Hepatic Lipoprotein Production by Glucose and FructoseCompletedNCT01694446Not applicable
• Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in HumansCompletedNCT01056549Not applicable